Angiographic and intravascular ultrasound assessment of immediate and 9-month efficacy of percutaneous transluminal renal artery balloon angioplasty with subsequent brachytherapy in patients with renovascular hypertension

Kidney and Blood Pressure Research

Volumn 31, Issue 5, 2008, Pages 291-298

  Lekston, Andrzej ^a,c   Chudek, Jerzy ^a   Ga̧sior, Mariusz ^a   Wilczek, Krzysztof ^a   Wiȩcek, Andrzej ^a   Kokot, Franciszek ^a   Gierlotka, Marek ^a   Niklewski, Tomasz ^a   Fijałkowski, Marek ^b   Szyguła Jurkiewicz, Bozena ^a   Wojnicz, Roman ^a   Białas, Brygida ^b   Osuch, Marcin ^a   Maciejewski, Bogusław ^b   Poloński, Lech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c MSC Maria Curie Slodowska Branch Gliwice ^*  (Poland)

Author keywords

Angiography; Brachytherapy; Intravascular brachytherapy; Intravascular ultrasound; Percutaneous transluminal renal artery balloon angioplasty; Renovascular hypertension; Ultrasound assessment

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; TICLOPIDINE;

ADULT; ANGIOGRAPHY; ARTERY THROMBOSIS; ARTICLE; BLOOD PRESSURE MONITORING; BRACHYTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; INTRAVASCULAR ULTRASOUND; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENOVASCULAR HYPERTENSION; RESTENOSIS; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ADULT; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; BLOOD PRESSURE; BRACHYTHERAPY; FEMALE; HUMANS; HYPERTENSION, RENOVASCULAR; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RENAL ARTERY OBSTRUCTION; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 50849113064     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000153249     Document Type: Article

References (25)

1. Garovic VD, Textor SC: Renovascular hypertension and ischemic nephropathy. Circulation 2005;112:1362-1374.
2. Textor SC: Renovascular hypertension in 2007: where are we now? Curr Cardiol Rep 2007;9:453-461.
3. Martin LG, Rundback JH, Sacks D, Cardella JF, Rees CR, Matsumoto AH, Meranze SG, Schartzberg MS, Silverstein MI, Lewis CA: Quality improvement guidelines for angiography, angioplasty, and stent placement in the diagnosis and treatment of renal artery stenosis in adults. J Vasc Interv Radiol 2003;14:S297-S310.
4. Watson PS, Hadjipetrou P, Cox SV, Piemonte TC, Eisenhauer AC: Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000;102:1671-1677.
5. Weintraub WS: The pathophysiology and burden of restenosis. Am J Cardiol 2007;100:3K-9K.
6. Plouin PF, Darne B, Chatellier G, Pannier I, Battaglia Ch, Raynaud A, Azizi M: Restenosis after a first percutaneous transluminal renal angioplasty. Hypertension 1993;21:89-96.
7. Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlbock M, Seitz W, Wolfram R, Potter R: Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty. Circulation 2000;102:2694-2699.
8. Mintz GS, Weissman NJ, Teirstein PS, Ellis SG, Waksman R, Russo RJ, Moussa I, Tripuraneni P, Jani S, Kobayashi Y, Giorgiani JA, Pappas C, Kuntz RA, Moses J, Leon MB: Effect of intracoronary gamma-radiation therapy on in-stent restenosis. An intravascular ultrasound analysis from the Gamma-1 study. Circulation 2000;102:2915-2918.
9. Coen V, Serruys P, Sauerwein W, Orecchia R, Von-Rottkay P, Coucke P, Ehnert M, Urban P, Bonan R, Levendag P: Reno, a European postmarket surveillance registry, confirms effectiveness of coronary brachytherapy in routine clinical practice. Int J Radiat Oncol Biol Phys 2003;55:1019-1026.
10. Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuteman S, Sirkin K, Cloutier DA, Leon MB, Tripuraneni P: Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2000;101:360-365.
11. Waksman R, Serruys P: Handbook of Vascular Brachytherapy. London, Dunitz, 1998.
12. Aslam M, Balasubramanian J, Greenspahn B: Brachytherapy for renal in-stent restenosis. Catheter Cardiovasc Interv 2003;58:151-154.
13. Stoeteknuel-Friedli S, Do DD, von Briel C, Triller J, Mahler F, Baumgartner I: Endovascular brachytherapy for prevention of recurrent renal in-stent restenosis. J Endovasc Ther 2002;9:350-353.
14. Gupta R, Zoghbi G, Aqel R: Brachytherapy for renal artery in-stent restenosis. Invasive Cardiol 2006;18:E227-E229.
15. Bonelli FS, McKusick MA, Textor SC, Kos PB, Stanson AW, Johnson CM, Sheedy PF 2nd, Welch TJ, Schirger A: Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc 1995;70:1041-1052.
16. Crowley JJ, Santos RM, Conlon PJ: Management of Renal Artery Stenosis: Interventional Cardiovascular Medicine. Principles and Practice, ed 2. Edinburgh, Churchill Livingstone, 2002.
17. Hoffman O, Carreres T, Sapoval MR, Auguste MC, Beyssen BM, Raynaud AC, Gaux JC: Ostial renal artery stenosis angioplasty: immediate and mid-term angiographic and clinical results. J Vasc Interv Radiol 1998;9:65-73.
18. Blum U, Krumme B, Flügel P, Gabelmann A, Lehnert T, Buitrago-Tellez C, Schollmeyer P, Langer M: Treatment of ostial renal artery stenoses with vascular endoprotheses after unsuccessful balloon angioplasty. N Engl J Med 1997;336:459-465.
19. Safian R, Textor S: Renal artery stenosis. N Engl J Med 2001;344:431-442.
20. Rocha-Singh K, Jaff MR, Rosenfield K: Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful angioplasty: the ASPIRE-2 study. J Am Coll Cardiol 2005;46:776-783.
21. Waksman R, Laird JR, Jurkovitz CT, Lansky AJ, Kosinski AS, Murrah N, Weintraub WS: Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial. J Vasc Interv Radiol 2001;2:915-921.
22. 192Ir HDR brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2 trial. Radiotherapy parameters and risk factors analysis. Int J Radiat Oncol Biol Phys 2000;48:923-931.
23. Wolfram RM, Budinsky AC, Pokrajac B, Potter R, Minar E: Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up - prospective randomized study. Radiology 2006;240:878-884.
24. Zähringer M, Sapoval M, Pattynama PM, Rabbia C, Vignali C, Maleux G, Boyer L, Szczerbo-Trojanowska M, Jaschke W, Hafsahl G, Downes M, Bérégi JP, Veeger NJ, Stoll HP, Talen A: Sirolimus-eluting versus baremetal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years. Endovasc Ther 2007;14:460-468.
25. Zeller T, Rastan A, Schwarzwälder U, Mueller C, Schwarz T, Frank U, Bürgelin K, Sixt S, Noory E, Beschorner U, Hauswald K, Branzan D, Neumann FJ: Treatment of in-stent restenosis following stent-supported renal artery angioplasty. Catheter Cardiovasc Interv 2007;70:454-459.